Seronegative blood products prevent primary cytomegalovirus infection after bone marrow transplantation. | Journal of Clinical Pathology

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via ACP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Citation Tools

Research Article

Seronegative blood products prevent primary cytomegalovirus infection after bone marrow transplantation.

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Mackinnon S, Burnett AK, Crawford RJ, et al

Seronegative blood products prevent primary cytomegalovirus infection after bone marrow transplantation.

Journal of Clinical Pathology 1988;41:948-950.